生理節律睡眠障礙市場規模、佔有率和成長分析：按疾病類型、療法、藥物類別、給藥途徑、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球生理節律睡眠障礙市場價值為 29 億美元，預計到 2033 年將從 2025 年的 31 億美元成長到 52.4 億美元，預測期（2026-2033 年）的複合年成長率為 6.8%。

全球生理節律睡眠障礙市場正經歷顯著的變革，這主要得益於對診斷、治療和數位健康工具的需求不斷成長，這些工具旨在解決諸如睡眠相位後移症候群和非24小時睡眠-覺醒週期紊亂等疾病。由於輪班工作和時差的增加，患者數量急劇成長，包括保險公司和雇主相關人員正在加大對時間療法的投資。穿戴式裝置和個人化醫療的融合正在推動市場動態。持續的褪黑激素資料收集使得精準的光療和褪黑激素處方成為可能。製藥公司正在開發標靶時間生理時鐘療法，由於預期療效顯著，保險公司也給予了積極的報銷。此外，穿戴式裝置製造商和睡眠診所之間的合作正在加速推進，促進了創新並吸引了投資，為未來幾年市場的顯著成長奠定了基礎。

全球生理節律睡眠障礙市場的成長要素

大眾和醫學界對生理節律睡眠障礙的認知不斷提高，導致尋求評估和診斷的人數增加。隨著醫療服務提供者在診療流程中更早採用診斷方案，需要治療的患者群體不斷擴大，從而推動了對特效藥物、行為療法和創新數位健康解決方案的需求。正式診斷數量的增加正在加強轉診網路，並擴大專業服務的覆蓋範圍。這為市場相關人員提供了持續的機會，使其能夠設計和推廣客製化治療方案，並在全球不同地區和不斷變化的醫療保健格局中提升自身影響力。

全球生理節律睡眠障礙市場的限制因素

全球生理節律睡眠障礙市場面臨的主要障礙之一是診斷測試和治療的保險覆蓋範圍有限。這項經濟挑戰導致患者不願接受全面的評估和長期管理方案，降低了對專業服務的需求。此外，由於報銷的不確定性，醫療服務提供者可能不願意採用創新的診斷和治療方法，這進一步限制了市場滲透率。因此，保險公司支持不足對整體市場成長產生負面影響，限制了患者獲得必要治療的機會，並減緩了該領域相關產品的商業性開發。解決這些經濟障礙對於推動市場擴張至關重要。

全球生理節律睡眠障礙市場趨勢

全球生理節律睡眠障礙市場正經歷著數位化整合的重大轉變，其特徵是數位治療平台的日益普及。這些解決方案透過智慧型手機和穿戴式技術提供個人化干預，使臨床醫生能夠開立基於應用程式的創新工具，用於睡眠指導、光照管理和行為指導。這一趨勢不僅為科技公司帶來了新的收入來源，也為患者提供了更多獲得有效治療方案的機會。隨著健康資訊科技和睡眠醫學的融合，持續的產品創新和跨產業合作正在重塑治療路徑，而數位化解決方案正成為提高患者依從性和整體健康結果的關鍵要素。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生理節律睡眠障礙市場規模：依障礙類型分類

• 睡眠-覺醒相位延遲障礙（DSWPD）
• 進行性睡眠-覺醒障礙（ASWPD）
• 非24小時睡眠-覺醒障礙（非24小時）
• 睡眠-覺醒週期紊亂症（ISWRD）
• 輪班工作睡眠障礙（SWSD）
• 時差反應 (JLD)

全球生理節律睡眠障礙市場規模：依治療類型分類

• 藥物治療
• 光療
• 行為療法和時間療法
• 聯合治療

全球生理節律睡眠障礙市場規模：依藥物類別分類

• 褪黑素和褪黑素受體促效劑
• 興奮劑
• 催眠藥和鎮靜劑
• 其他

全球生理節律睡眠障礙市場規模：依給藥途徑分類

• 口服
• 注射藥物
• 經皮給藥

全球生理節律睡眠障礙市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球生理節律睡眠障礙市場規模：依最終用戶分類

• 醫院
• 睡眠診所及睡眠中心
• 居家醫療
• 專科診所

全球生理節律睡眠障礙市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Vanda Pharmaceuticals Inc.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals plc
• Eisai Co. Ltd.
• Sanofi SA
• Pfizer Inc.
• Merck & Co. Inc.
• Koninklijke Philips NV
• Luminette
• Sleepace
• PEGASI
• ResMed Inc.
• Fisher & Paykel Healthcare Corporation Limited
• Natus Medical Incorporated
• Compumedics Limited
• ActiGraph LLC
• Advanced Brain Monitoring Inc.
• Shionogi & Co. Ltd.
• Lucimed SA

結論與建議

Global Circadian Rhythm Sleep Disorders Market size was valued at USD 2.90 Billion in 2024 and is poised to grow from USD 3.10 Billion in 2025 to USD 5.24 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global market for circadian rhythm sleep disorders is witnessing significant transformation, driven by increased demand for diagnostics, therapeutics, and digital health tools addressing conditions like delayed sleep-phase syndrome and non-24-hour sleep-wake disorder. The rising prevalence of shift work and jet lag has notably expanded the patient population, with stakeholders, including insurers and employers, investing in chronotherapy initiatives. The convergence of wearables and personalized medicine is enhancing market dynamics; continuous melatonin data allow for precise light therapy and melatonin prescriptions. Pharmaceutical firms are developing targeted chronobiotic treatments that insurers are willing to reimburse due to favorable outcomes. Additionally, collaborations between wearable manufacturers and sleep clinics are gaining traction, fostering innovation and attracting investment, positioning the market for substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circadian Rhythm Sleep Disorders market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circadian Rhythm Sleep Disorders Market Segments Analysis

Global circadian rhythm sleep disorders market is segmented by disorder type, treatment type, drug class, route of administration, distribution channel, end user and region. Based on disorder type, the market is segmented into delayed sleep-wake phase disorder (DSWPD), advanced sleep-wake phase disorder (ASWPD), non-24-hour sleep-wake disorder (Non-24), irregular sleep-wake rhythm disorder (ISWRD), shift work sleep disorder (SWSD) and jet lag disorder (JLD). Based on treatment type, the market is segmented into pharmacological therapy, light therapy, behavioral & chronotherapy and combination therapy. Based on drug class, the market is segmented into melatonin & melatonin receptor agonists, wake-promoting agents, hypnotics & sedative medications and others. Based on route of administration, the market is segmented into oral, injectable and transdermal. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end user, the market is segmented into hospitals, sleep clinics & sleep centers, home care settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circadian Rhythm Sleep Disorders Market

The growing recognition of circadian rhythm sleep disorders among the public and within the medical community is leading to a higher number of individuals seeking evaluation and diagnosis. As healthcare providers adopt diagnostic protocols earlier in care pathways, the pool of patients requiring treatment broadens, driving demand for specialized medications, behavioral therapies, and innovative digital health solutions. With an increase in formal diagnoses, referral networks are strengthened, and the availability of specialist services expands. This creates ongoing opportunities for market stakeholders to design and promote customized treatment options, enhancing their presence in diverse geographical areas and evolving healthcare environments across the globe.

Restraints in the Global Circadian Rhythm Sleep Disorders Market

A significant obstacle in the Global Circadian Rhythm Sleep Disorders market is the limited coverage offered by insurance policies for diagnostic testing and treatment. This financial challenge discourages patients from pursuing thorough evaluations and long-term management solutions, leading to decreased demand for specialized services. Additionally, providers may hesitate to adopt innovative diagnostics and therapies due to uncertain reimbursement, which further restricts market penetration. Consequently, inconsistent support from payers negatively affects overall growth, reduces access to essential treatments, and slows the commercial development of related products within this sector. Addressing these financial barriers is crucial for fostering market expansion.

Market Trends of the Global Circadian Rhythm Sleep Disorders Market

The Global Circadian Rhythm Sleep Disorders market is experiencing a significant shift towards digital integration, marked by the growing adoption of digital therapeutics platforms. These solutions offer personalized interventions via smartphones and wearable technology, allowing clinicians to prescribe innovative app-based tools for sleep coaching, light exposure management, and behavioral nudges. This trend not only generates new revenue streams for technology companies but also enhances patient access to effective treatment options. As health IT merges with sleep medicine, ongoing product innovation and cross-industry collaborations are reshaping therapeutic care pathways, establishing digital solutions as essential components for improving patient adherence and overall health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Circadian Rhythm Sleep Disorders Market Size by Disorder Type & CAGR (2026-2033)

• Market Overview
• Delayed Sleep-Wake Phase Disorder (DSWPD)
• Advanced Sleep-Wake Phase Disorder (ASWPD)
• Non-24-Hour Sleep-Wake Disorder (Non-24)
• Irregular Sleep-Wake Rhythm Disorder (ISWRD)
• Shift Work Sleep Disorder (SWSD)
• Jet Lag Disorder (JLD)

Global Circadian Rhythm Sleep Disorders Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological Therapy
• Light Therapy
• Behavioral & Chronotherapy
• Combination Therapy

Global Circadian Rhythm Sleep Disorders Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Melatonin & Melatonin Receptor Agonists
• Wake-Promoting Agents
• Hypnotics & Sedative Medications
• Others

Global Circadian Rhythm Sleep Disorders Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Transdermal

Global Circadian Rhythm Sleep Disorders Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Circadian Rhythm Sleep Disorders Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Sleep Clinics & Sleep Centers
• Home Care Settings
• Specialty Clinics

Global Circadian Rhythm Sleep Disorders Market Size & CAGR (2026-2033)

• North America (Disorder Type, Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User)
  • US
  • Canada
• Europe (Disorder Type, Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disorder Type, Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disorder Type, Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disorder Type, Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Vanda Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jazz Pharmaceuticals plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminette
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sleepace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PEGASI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ActiGraph LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Brain Monitoring Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shionogi & Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucimed SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations